Model‐free scoring system for risk prediction with application to hepatocellular carcinoma study
暂无分享,去创建一个
Ying Yuan | Jing Ning | Anna S Lok | Weining Shen | Ziding Feng | A. Lok | Ziding Feng | Ying Yuan | Weining Shen | J. Ning
[1] R. Fontana,et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. , 2006, Gastrointestinal endoscopy.
[2] David Sidransky,et al. Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.
[3] Xiwei Chen,et al. Empirical likelihood ratio confidence interval estimation of best linear combinations of biomarkers , 2015, Comput. Stat. Data Anal..
[4] Enrique F Schisterman,et al. On linear combinations of biomarkers to improve diagnostic accuracy , 2005, Statistics in medicine.
[5] Charles Kooperberg,et al. Combining biomarkers to detect disease with application to prostate cancer. , 2003, Biostatistics.
[6] I. Johnstone,et al. Ideal spatial adaptation by wavelet shrinkage , 1994 .
[7] H. Ding,et al. Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein , 2003, British Journal of Cancer.
[8] Jian Huang,et al. Regularized ROC method for disease classification and biomarker selection with microarray data , 2005, Bioinform..
[9] M. C. Jones. The performance of kernel density functions in kernel distribution function estimation , 1990 .
[10] P. Song,et al. Serum biomarkers for early diagnosis of hepatocellular carcinoma , 2014 .
[11] J. Everhart,et al. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. , 2009, Gastroenterology.
[12] L. Lawrence. Incidence of Hepatocellular Carcinoma May Decline , 2016 .
[13] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[14] Xiwei Chen,et al. Statistical Testing Strategies in the Health Sciences , 2016 .
[15] Jianqing Fan,et al. Variable Selection via Nonconcave Penalized Likelihood and its Oracle Properties , 2001 .
[16] Debashis Ghosh,et al. Combining Multiple Biomarker Models in Logistic Regression , 2008, Biometrics.
[17] Tianxi Cai,et al. Resampling Procedures for Making Inference Under Nested Case–Control Studies , 2013, Journal of the American Statistical Association.
[18] Pengfei Li,et al. Using a Monotonic Density Ratio Model to Find the Asymptotically Optimal Combination of Multiple Diagnostic Tests , 2016 .
[19] Ying Yuan,et al. A direct method to evaluate the time‐dependent predictive accuracy for biomarkers , 2015, Biometrics.
[20] William M. Lee,et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. , 2010, Gastroenterology.
[21] Hao Helen Zhang,et al. Adaptive Lasso for Cox's proportional hazards model , 2007 .
[22] Jianjun Gao,et al. Biomarkers: Evaluation of Screening for and Early Diagnosis of Hepatocellular Carcinoma in Japan and China , 2013, Liver Cancer.
[23] Tuo Zhao,et al. Pathwise Coordinate Optimization for Sparse Learning: Algorithm and Theory , 2014, ArXiv.
[24] T. Cai,et al. Combining Predictors for Classification Using the Area under the Receiver Operating Characteristic Curve , 2006, Biometrics.
[25] J. Everhart,et al. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. , 2009, Gastroenterology.
[26] A. Burroughs,et al. A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] Margaret Sullivan Pepe,et al. Combining Several Screening Tests: Optimality of the Risk Score , 2002, Biometrics.
[28] D. Harnois. Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease , 2009 .
[29] X. Wang,et al. Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma , 2013, Clinical Cancer Research.
[30] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[31] Jun S. Liu,et al. Linear Combinations of Multiple Diagnostic Markers , 1993 .
[32] Y. Chang. Maximizing an ROC‐type measure via linear combination of markers when the gold reference is continuous , 2013, Statistics in medicine.
[33] Matthias Schmid,et al. Boosting the Concordance Index for Survival Data – A Unified Framework To Derive and Evaluate Biomarker Combinations , 2013, PloS one.
[34] Tianxi Cai,et al. Application of the Time‐Dependent ROC Curves for Prognostic Accuracy with Multiple Biomarkers , 2006, Biometrics.
[35] D. Harnois,et al. Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .
[36] H. Zou. The Adaptive Lasso and Its Oracle Properties , 2006 .
[37] M. Zoli,et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. , 2010, Journal of hepatology.
[38] J. Wu,et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. , 2004, Thyroid : official journal of the American Thyroid Association.
[39] M. Alter,et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. , 2010, Gastroenterology.
[40] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[41] M. Pepe,et al. Combining diagnostic test results to increase accuracy. , 2000, Biostatistics.
[42] P. Heagerty,et al. Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.
[43] Donglin Zeng,et al. Efficient Estimation for the Accelerated Failure Time Model , 2007 .